{"acute kidney injury": 2.45, "angioedema": 2.15, "ascites": 4.2, "blood creatinine increased": 2.67, "breast cancer": 8.5, "breast cancer metastatic": 48.41, "cytomegalovirus infection": 15.19, "dehydration": 2.63, "disease progression": 4.62, "drug interaction": 6.22, "drug intolerance": 4.67, "drug level increased": 8.97, "drug resistance": 5.34, "general physical health deterioration": 3.0, "hypothyroidism": 2.47, "immunosuppressant drug level increased": 41.08, "interstitial lung disease": 3.01, "leukopenia": 3.9, "lung disorder": 2.55, "lung infiltration": 12.17, "malignant neoplasm progression": 19.73, "metastases to bone": 32.49, "metastases to liver": 51.78, "metastases to lung": 38.19, "metastases to lymph nodes": 25.45, "metastatic renal cell carcinoma": 15.33, "mouth ulceration": 5.47, "mucosal inflammation": 8.73, "neoplasm progression": 6.25, "neuroendocrine tumour": 69.33, "palmar-plantar erythrodysaesthesia syndrome": 4.26, "pancreatic neuroendocrine tumour": 124.43, "pik3ca-activated mutation": 246.19, "pleural effusion": 3.31, "pneumonitis": 14.21, "product use in unapproved indication": 5.44, "renal cell carcinoma": 17.55, "renal impairment": 2.6, "respiratory failure": 3.07, "stomatitis": 7.27, "thrombocytopenia": 2.38, "toxicity to various agents": 5.19, "treatment failure": 2.29}